 Humanised antibodies are produced by grafting murine hypervariable regions on amino acid domains into human antibodies.This results in a molecule of approximately 95% human origin.Humanised antibodies bind antigen much more weakly than the parent murine monoclonal antibody, with reported decreases in affinity of up to several hundredfold.